Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended versus standard oral amoxicillin-clavulanate after severe pediatric pneumonia
ACTRN12616000046404Phase 4Completed
- Sponsor
- Menzies School of Health Research
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial in pneumonia comparing Extended amoxicillin-clavulanate with Placebo after initial amoxicillin-clavulanate (2 arms). Primary endpoint: Proportion without chronic respiratory symptoms and signs or bronchiectasis. Started May 2016; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
pneumonia
Beyond the preview
Go deeper on ACTRN12616000046404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000046404.